- Report
- September 2025
- 30 Pages
United States
From €995EUR$1,188USD£904GBP
- Report
- September 2025
- 27 Pages
Belgium
From €995EUR$1,188USD£904GBP
- Report
- September 2025
- 28 Pages
Japan
From €995EUR$1,188USD£904GBP
- Report
- September 2025
- 25 Pages
Norway
From €995EUR$1,188USD£904GBP
- Report
- September 2025
- 23 Pages
Cameroon
From €995EUR$1,188USD£904GBP
- Report
- September 2025
- 27 Pages
Mexico
From €995EUR$1,188USD£904GBP
- Report
- September 2025
- 24 Pages
Chile
From €995EUR$1,188USD£904GBP
- Report
- September 2025
- 24 Pages
Colombia
From €995EUR$1,188USD£904GBP
- Report
- September 2025
- 26 Pages
South Korea
From €995EUR$1,188USD£904GBP
- Report
- September 2025
- 23 Pages
Argentina
From €995EUR$1,188USD£904GBP
- Report
- September 2025
- 27 Pages
Austria
From €995EUR$1,188USD£904GBP
From €995EUR$1,188USD£904GBP
- Report
- September 2025
- 22 Pages
Azerbaijan
From €995EUR$1,188USD£904GBP
- Report
- September 2025
- 22 Pages
Bolivia
From €995EUR$1,188USD£904GBP
- Report
- April 2025
- 221 Pages
China
From €3589EUR$4,000USD£3,150GBP
- Report
- April 2025
- 28 Pages
Brazil
From €995EUR$1,188USD£904GBP
- Report
- January 2025
- 132 Pages
Global
From €852EUR$950USD£748GBP
- Report
- January 2025
- 132 Pages
Global
From €852EUR$950USD£748GBP
- Report
- January 2025
- 132 Pages
Global
From €852EUR$950USD£748GBP
- Report
- January 2025
- 132 Pages
Global
From €852EUR$950USD£748GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more